Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters

Complementary Medicines
Country/Region as subject
Publication year range
1.
Mol Neurobiol ; 58(8): 3665-3676, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33797061

ABSTRACT

We examined the neuropharmacological effects of ethanol extract of Ficus erecta Thunb leaves (EEFE) on cognitive dysfunction in a scopolamine (SCO)-induced memory impairment animal model. Memory impairment was measured using the Y-maze test and passive avoidance task (PAT). For 19 days, EEFE (100 or 200 mg/kg) was treated through oral administration. Treatment with EEFE ameliorated memory impairment in behavioral tests, along with significant protection from neuronal oxidative stress and neuronal cell loss in the brain tissues of SCO-injected mice. Antioxidant and neuroprotective effects of EEFE were further confirmed using in vitro assays. Our findings indicate that the mechanisms of neuroprotection and antioxidation of EEFE are regulated by the cholinergic system, promotion of cAMP response element-binding protein (CREB) phosphorylation, and the nuclear factor erythroid-2-related factor 2 (Nrf2)/heme oxygenase (HO)-1 signaling activation. The current study proposes that EEFE could be an encouraging plant resource and serve as a potent neuropharmacological drug candidate against neurodegenerative diseases.


Subject(s)
Cholinergic Neurons/drug effects , Ficus , Memory Disorders/drug therapy , Oxidative Stress/drug effects , Plant Extracts/therapeutic use , Scopolamine/toxicity , Animals , Cell Line , Cholinergic Antagonists/toxicity , Cholinergic Neurons/metabolism , Dose-Response Relationship, Drug , Male , Memory Disorders/chemically induced , Memory Disorders/metabolism , Mice , Mice, Inbred ICR , Oxidative Stress/physiology , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Plant Leaves
2.
Toxicon ; 177: 52-88, 2020 Apr 15.
Article in English | MEDLINE | ID: mdl-32217234

ABSTRACT

Datura stramonium, Atropa belladonna, Hyoscyamus niger, and Scopolia carniolica are all temperate plants from the family Solanaceae, which as a result of their anticholinergic tropane alkaloids, hyoscyamine/atropine and scopolamine, have caused many cases of poisoning around the world. Despite the danger these nightshade plants represent, the literature often presents incomplete cases lacking in details and filled with ambiguity, and reviews on the topic tend to be limited in scope. Many also point to a gap in knowledge of these plants among physicians. To address this, the following review focuses on intoxications involving these plants as reported in the literature between 1966 and 2018, with brief mention to pertinent related plants to contextualise and provide a fuller picture of the situation surrounding the presently discussed temperate plants. Analysis of the literature displays that D. stramonium is largely associated with drug use among teens while A. belladonna is primarily ingested as a result of the berries being mistaken for edible fruits. H. niger was found to be largely ingested when mistaken for other plants, and S. carniolica was the cause of incredibly few intoxications.


Subject(s)
Cholinergic Antagonists/toxicity , Plant Extracts/toxicity , Plant Poisoning/epidemiology , Solanaceae , Solanaceous Alkaloids/toxicity , Alkaloids , Atropa belladonna , Europe , Humans , Hyoscyamus , Scopolamine , Scopolia , Tropanes
3.
Cent Nerv Syst Agents Med Chem ; 19(2): 125-132, 2019.
Article in English | MEDLINE | ID: mdl-30836928

ABSTRACT

OBJECTIVE: The present study was designed to investigate the potential of Pistacia vera (P. vera) fruits in experimental memory impairments in mice. MATERIAL & METHODS: Memory impairment was induced in Swiss Albino mice by scopolamine (0.4mg mg/kg. i.p). Animals were divided into five separate groups of six animals each, positive control group received carboxy methyl cellulose (CMC) as vehicle, negative control group received scopolamine with vehicle, and standard group received donepezil (5mg/kg i.p) with Scopolamine. Ethanolic extract of P. vera (EEPV) at doses of 200mg/kg & 400mg/kg p.o were administered to group test1 & test 2 respectively along with scopolamine. Elevated plus maze (EPM), passive avoidance paradigms and morris water maze (MWM) were used as exteroceptive behavioral models to access learning and memory activity. Transfer latency, step down latency and escape latency parameters were evaluated plus maze, passive avoidance paradigm, morris water maze. Thereafter lipid peroxidation test, glutathione level and catalase activities were estimated in homogenized brain of mice. RESULTS: Pretreatment of mice with EEPV (200mg/kg & 400mg/kg) significantly reduced scopolamine induced amnesia. The obtained data clearly revealed that there was increase in escape latency in MWM and also increase in step down latency in passive avoidance paradigm. Transfer latencey was found to be decrease in EPM and biochemical. Parameters were clearly satisfied the data as compared to negative control group which was indicative of cognitive improvement. CONCLUSION: P. vera fruit extract demonstrated to improve cognitive process by enhancing memory in different experimental paradigm such as EPM, passive avoidance and MWM when administered orally. Hence it would be worthwhile to explore the potential of this plant in the management of memory disorders.


Subject(s)
Maze Learning/drug effects , Memory Disorders/drug therapy , Memory/drug effects , Pistacia , Plant Extracts/pharmacology , Scopolamine/toxicity , Animals , Cholinergic Antagonists/toxicity , Dose-Response Relationship, Drug , Female , Fruit , Male , Maze Learning/physiology , Memory/physiology , Memory Disorders/chemically induced , Mice , Plant Extracts/isolation & purification , Plant Extracts/therapeutic use
4.
Biomed Pharmacother ; 111: 496-502, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30594789

ABSTRACT

Certain biflavonoids have been proven to protect against cognitive dysfunction. A new biflavonoid, CGY-1, isolated from Cardiocrinum giganteum seeds, has not yet been reported to have any neuroprotective effect. In this study, a scopolamine-induced memory deficit model was used to explore the neuroprotective effect of CGY-1. Behavioral experiments, such as tests using the Morris water maze, the Y-maze and the fear conditioning test, were conducted. The results revealed that oral administration of CGY-1 (20 and 40 mg/kg) and donepezil shortened the escape latency, improved the percentage of spontaneous alternation, and increased the freezing times, respectively. CGY-1 decreased the levels of reactive oxygen species and malondialdehyde and increased the activities of superoxide dismutase and glutathione peroxidase in the hippocampus. In addition, CGY-1 decreased the activity of acetylcholinesterase and increased the activities of choline acetyltransferase and acetylcholine in the hippocampus. Furthermore, qPCR and western blot results revealed that the expressions of neurotrophic factors, brain-derived neurotrophic factor and nerve growth factor were upregulated in the hippocampus after CGY-1 treatment. In conclusion, CGY-1 could be a promising candidate for the treatment of cognitive dysfunction.


Subject(s)
Biflavonoids/therapeutic use , Cholinergic Neurons/drug effects , Drugs, Chinese Herbal/therapeutic use , Lilium , Memory Disorders/drug therapy , Scopolamine/toxicity , Animals , Biflavonoids/isolation & purification , Biflavonoids/pharmacology , Cholinergic Antagonists/toxicity , Cholinergic Neurons/metabolism , Drugs, Chinese Herbal/isolation & purification , Drugs, Chinese Herbal/pharmacology , Male , Memory Disorders/chemically induced , Memory Disorders/metabolism , Mice , Oxidative Stress/drug effects , Oxidative Stress/physiology , Seeds
5.
Int J Mol Sci ; 19(2)2018 Jan 25.
Article in English | MEDLINE | ID: mdl-29370115

ABSTRACT

Though Oldenlandia diffusa Herba (ODH) has been known to exhibit anti-cancer and anti-inflammatory effects, its anti-amnestic effect has never been reported so far. The aim of this present study was to elucidate the anti-amnestic effect of ODH. ODH pretreatment significantly reduced escape latency of scopolamine treated Institute of Cancer Research (ICR) mice compared to untreated control groups in a Morris water maze test. Similarly, the passive avoidance test showed that ODH treatment recovered the scopolamine induced amnesia in the ICR mouse model. Concentration of Ach in brains of ODH treated mice was increased compared to that of scopolamine treated mice. In addition, activity of acetylcholinesterase (AChE) was notably decreased by ODH. The protein expression of brain-derived neurotrophic factor (BDNF) and phospho-cAMP response element-binding protein (p-CREB) (Ser133) was increased in ODH pretreated group compared to control group. Consistently, immunohistochemistry (IHC) revealed the elevated expression of brain-derived neurotrophic factor (BDNF) and p-CREB in brains of ODH treated mice compared to the control group. Overall, these findings suggest that ODH has anti-amnestic potential via activation of BDNF and p-CREB and inhibition of AChE in mice with scopolamine induced amnesia.


Subject(s)
Cholinesterase Inhibitors/pharmacology , Cognitive Dysfunction/drug therapy , Neuroprotective Agents/pharmacology , Oldenlandia/chemistry , Plant Extracts/pharmacology , Acetylcholine/metabolism , Acetylcholinesterase/metabolism , Animals , Brain/drug effects , Brain/metabolism , Brain-Derived Neurotrophic Factor/metabolism , Cholinergic Antagonists/toxicity , Cholinesterase Inhibitors/therapeutic use , Cognitive Dysfunction/etiology , Cyclic AMP Response Element-Binding Protein/metabolism , Male , Mice , Mice, Inbred ICR , Neuroprotective Agents/therapeutic use , Plant Extracts/therapeutic use , Scopolamine/toxicity
7.
J Ethnopharmacol ; 193: 474-480, 2016 Dec 04.
Article in English | MEDLINE | ID: mdl-27693774

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Seeds of Sisymbrium irio Linn has been used traditionally in different regions of Pakistan for the treatment of gastrointestinal, airways and vascular system ailments. To insight the pharmacological basis, in vitro study was conducted in order to validate its folkloric uses. MATERIAL AND METHODS: 70% aqueous-methanolic extract of seeds from S. irio (Si.MEs) was tested on isolated rabbit aorta, jejunum and trachea strip hanged in tissue bath having physiological solutions aerated with carbogen and their responses were measured and recorded via Power Lab. RESULTS: The Si.MEs exhibited the transient spasmogenic effect (0.01-1.0mg/mL) on spontaneous jejunum contractions, followed by the spasmolytic effect. The addition of atropine resulted in blocking in spasmogenic effect while the spasmolytic effect was originated, suggesting the presence of an antimuscarinic effect. Likewise verapamil, Si.MEs (0.03-5mg/mL) repressed the high concentration K+(80mM)-induced contraction and also drifted the Ca2+ concentration-response curves toward right (0.3-3.0mg/mL), possibly signifying the Ca2+ channel blockade. Furthermore, Si.MEs exhibited nonspecific relaxant effect on carbachol (1µM)- and high concentration K+(80mM)-induced tracheal contractions in a way comparable to dicyclomine, suggesting the coexistence of Ca2+-antagonistic and/or antimuscarinic properties. Additionally, Si.MEs also relaxed the phenylephrine(1µM)- and high concentration K+(80mM)-induced aortic contraction (0.01-3mg/mL), suggesting blockade of Ca2+ channel. Moreover, oral administration of Si.MEs, as high as 6g per kg, did not produce lethality among the treated groups of mice. CONCLUSIONS: Aqueous-methanolic extract of seeds from S. irio (Si.MEs) exhibited the bronchodilator and gut modulator (spasmogenic and spasmolytic) activities, probably through dual blockade of muscarinic receptors and Ca2+ channels, whereas, vasodilator effect may be due to Ca2+ channels blockade.


Subject(s)
Aorta/drug effects , Brassicaceae/chemistry , Calcium Channel Blockers/pharmacology , Cholinergic Antagonists/pharmacology , Folklore , Jejunum/drug effects , Plant Extracts/pharmacology , Trachea/drug effects , Animals , Bronchodilator Agents/isolation & purification , Bronchodilator Agents/pharmacology , Calcium Channel Blockers/isolation & purification , Calcium Channel Blockers/toxicity , Cholinergic Antagonists/isolation & purification , Cholinergic Antagonists/toxicity , Dose-Response Relationship, Drug , Ethnobotany , Ethnopharmacology , Female , Gastrointestinal Agents/isolation & purification , Gastrointestinal Agents/pharmacology , Gastrointestinal Motility/drug effects , In Vitro Techniques , Male , Methanol/chemistry , Mice , Muscle Contraction/drug effects , Phytotherapy , Plant Extracts/isolation & purification , Plant Extracts/toxicity , Plants, Medicinal , Rabbits , Seeds/chemistry , Solvents/chemistry , Vasoconstriction/drug effects , Vasodilator Agents/isolation & purification , Vasodilator Agents/pharmacology
8.
J Ethnopharmacol ; 193: 107-116, 2016 Dec 04.
Article in English | MEDLINE | ID: mdl-27492328

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: G. rigescens Franch (Long Dan Cao in Chinese) is a well-known TCM herb. It is clinically used with other drugs for the treatment of brain diseases such as epilepsy, postherpetic neuralgia in China. AIM OF STUDY: In our previous study, the 11 dihydroxybenzoates compounds with NGF mimicking activity from G. rigescens Franch were found. In the present study, the neurogenesis and neuroprotection of a mixture of benzoates ( n-GS) were investigated in animal level. MATERIALS AND METHODS: The NGF mimicking activity of n-GS from G. rigescens Franch was examined in PC12 cells. The neurogenesis effects of n-GS were investigated in ICR mice with 5-bromo-2-deoxyuridine (BrdU) and neuronal neclei (NeuN) double immunostaining. Furthermore, the neuroprotection effects of n-GS on the memory in a scopolamine (SCO)-induced mouse model were evaluated with animal behavior tests. RESULTS: The NGF-mimicking function and neurogenesis of n-GS were observed in PC12 cells and in normal mice. Subsequently, we investigated the effects of n-GS on the memory in a SCO-induced mouse model. In Y-maze test, SCO significantly lowered the alternation. This finding was reversed by n-GS and donepezil (DONE). SCO significantly impaired the mice's performance in novel object recognition (NOR) and Morris water maze (MWM) tests. The time spent to explore the novel object was longer in the n-GS- and DONE-treated groups than in the SCO control group. In the MWM test, the escape latency of n-GS- and DONE-treated groups was shorter than that of the SCO control group. Mechanism study showed that SCO significantly reduced superoxide dismutase (SOD) but increased the activities of acetylcholinesterase (AChE) and the levels of malondialdehyde (MDA) in the hippocampus and cerebral cortex, which all can be improved by n-GS and DONE. Additionally, the phosphorylation of type 1 insulin-like growth factor (IGF-1) receptor, extracellular signal-regulated kinase (ERK), and cAMP responsive element-binding (CREB) protein in the hippocampus was significantly up-regulated in the treatment group compared with that in the SCO group. CONCLUSIONS: n-GS could alleviate impaired memory of the SCO-induced mice model by inhibiting AChE activity and oxidative stress, and regulating the IGF-1R/ERK signaling pathway.


Subject(s)
Gentiana/chemistry , Memory Disorders/drug therapy , Plant Preparations/pharmacology , Animals , Benzoates , Cholinergic Antagonists/toxicity , Memory Disorders/chemically induced , Mice , Mice, Inbred ICR , Scopolamine/toxicity
9.
Nutr Neurosci ; 19(3): 125-30, 2016.
Article in English | MEDLINE | ID: mdl-25216329

ABSTRACT

Gumiganghwal-tang (GT) is a traditional herbal medicine that is widely used for its anti-inflammatory, analgesic, and antipyretic actions. Fermented GT has been reported to inhibit acetylcholinesterase (AChE) activity and to exert a neuroprotective effect. In this study, we investigated the effect of fermented GT against scopolamine-induced memory impairment in mice using the Morris water maze and passive avoidance tests. The results of the Morris water maze test indicated that fermented GT significantly decreased escape latency, as compared with that observed in the scopolamine-treated group. In the prove test, fermented GT attenuated the decreased time spent in the target quadrant observed after scopolamine treatment. The results of the passive avoidance test indicated that the treatment with fermented GT increased latency time when compared with the scopolamine-treated group. Moreover, fermented GT inhibited AChE activity in the hippocampi of the treated mice. These results suggest that fermented GT reduced scopolamine-induced amnesia in mice through AChE inhibition. Therefore, we hypothesize that fermented GT may be a useful therapeutic agent for the prevention or treatment of neurodegenerative diseases.


Subject(s)
Cholinesterase Inhibitors/therapeutic use , Dietary Supplements , Disease Models, Animal , Memory Disorders/prevention & control , Nootropic Agents/therapeutic use , Plant Extracts/therapeutic use , Acetylcholinesterase/metabolism , Animals , Avoidance Learning/drug effects , Behavior, Animal/drug effects , Cholinergic Antagonists/toxicity , Cholinesterase Inhibitors/administration & dosage , Donepezil , Fermentation , GPI-Linked Proteins/antagonists & inhibitors , GPI-Linked Proteins/metabolism , Hippocampus/drug effects , Hippocampus/enzymology , Indans/therapeutic use , Male , Maze Learning/drug effects , Memory Disorders/chemically induced , Memory Disorders/enzymology , Mice, Inbred ICR , Muscarinic Antagonists/toxicity , Nerve Tissue Proteins/antagonists & inhibitors , Nerve Tissue Proteins/metabolism , Neurons/drug effects , Neurons/enzymology , Nootropic Agents/administration & dosage , Piperidines/therapeutic use , Plant Extracts/administration & dosage , Republic of Korea , Scopolamine/toxicity
10.
Neurol Sci ; 36(4): 553-60, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25367404

ABSTRACT

Alzheimer's disease (AD) is a progressive neurological disorder that mostly affects the elderly population. Learning and memory impairment as the most characteristic manifestation of dementia could be induced chemically by scopolamine, a cholinergic antagonist. Cholinergic neurotransmission mediated brain oxidative stress. Citrus aurantium (CA) has traditionally been used for the treatment of insomnia, anxiety and epilepsy. The present study was designed to investigate the effect of Citrus aurantium on scopolamine-induced learning and memory deficit in rats. Forty-two Wistar rats were divided into six equal groups. (1) Control (received saline), (2) SCOP (scopolamine at a dose of 1 mg/kg for 15 days), (3) and (4) SCOP + CA (scopolamine and CA extract at doses of 300 and 600 mg/kg per day for 15 days), (5) and (6) intact groups (CA extract at 300 and 600 mg/kg per day for 15 days, respectively). Administration of CA flower extract significantly restored memory and learning impairments induced by scopolamine in the passive avoidance test and also reduced escape latency during trial sessions in the Morris water maze test. Citrus aurantium flower extract significantly decreased the serum malondialdehyde (MDA) levels. Citrus aurantium flower extract has repairing effects on memory and behavioral disorders produced by scopolamine and may have beneficial effects in the treatment of AD.


Subject(s)
Citrus , Flowers/chemistry , Memory Disorders/drug therapy , Plant Extracts/therapeutic use , Acetylcholinesterase , Analysis of Variance , Animals , Antioxidants/metabolism , Avoidance Learning/drug effects , Brain/metabolism , Cholinergic Antagonists/toxicity , Disease Models, Animal , Dose-Response Relationship, Drug , Ferric Compounds/blood , Male , Malondialdehyde/metabolism , Memory Disorders/chemically induced , Memory Disorders/pathology , Rats , Reaction Time/drug effects , Scopolamine/toxicity , Spatial Learning/drug effects
11.
Indian J Exp Biol ; 50(10): 690-5, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23214261

ABSTRACT

Present study involves evaluation of effects of 75% ethanolic extract of seabuckthorn [Hippophae rhamnoides L. (SBT)] leaves on scopolamine induced cognitive impairment in rats using three different oral doses i.e. 50, 100 and 200 mg/kg body weight through assessment of various biochemical and behavioural parameters. Scopolamine administration resulted in an increase in acetylcholinesterase (AChE) activity (approximately 9% with respect to the control group) and malonaldehyde (MDA) content. The increased AChE activity was significantly reduced in animals receiving 200 and 100 mg/kg of SBT extract. Animals treated with SBT extract showed significantly reduced MDA level in all the doses. This reduction in MDA content indicates that SBT leaf extract has potent antioxidant activities and exhibits a protective effect against oxidative damage induced by scopolamine. Behavioural studies also indicated significant improvement. The results suggest that SBT leaf extract has potential effects against scopolamine induced cognitive impairment by regulating cholinergic marker enzyme activity (AChE activity) and promoting the antioxidant system and may be explored for its use in cognitive disorders.


Subject(s)
Behavior, Animal/drug effects , Cognition Disorders/drug therapy , Hippophae/chemistry , Phytotherapy , Plant Extracts/therapeutic use , Plant Leaves/chemistry , Scopolamine/toxicity , Acetylcholinesterase/metabolism , Animals , Antioxidants/therapeutic use , Brain/drug effects , Brain/metabolism , Cholinergic Antagonists/toxicity , Cognition Disorders/chemically induced , Cognition Disorders/metabolism , Lipid Peroxidation/drug effects , Male , Malondialdehyde/metabolism , Oxidation-Reduction , Rats , Rats, Sprague-Dawley
12.
Arch Pharm Res ; 33(10): 1685-90, 2010 Oct.
Article in English | MEDLINE | ID: mdl-21052945

ABSTRACT

In this study, the effect of daidzin or daidzein isolated from Pueraria lobata on the memory impairments induced by scopolamine was assessed in male mice using the passive avoidance and the Morris water maze tasks. Administration of daidzin (5 mg/kg) or daidzein (5 mg/kg) significantly reversed the scopolamine (1 mg/kg)-induced cognitive impairments in male mice as evidenced by the passive avoidance test (p < 0.05) and on the Morris water maze test (p < 0.05). Moreover, the ameliorating effects of daidzin or daidzein were antagonized by tamoxifen (1 mg/kg), the nonspecific estrogen receptor antagonist. These results indicate that daidzin or daidzein may be useful in cognitive impairment induced by cholinergic dysfunction, and this beneficial effect is mediated, in part, via estrogen receptor.


Subject(s)
Cholinergic Antagonists/toxicity , Isoflavones/therapeutic use , Learning Disabilities/prevention & control , Memory Disorders/prevention & control , Phytoestrogens/therapeutic use , Scopolamine/toxicity , Animals , Avoidance Learning/drug effects , Estrogen Antagonists/pharmacology , Glucosides/antagonists & inhibitors , Glucosides/therapeutic use , Isoflavones/antagonists & inhibitors , Learning Disabilities/chemically induced , Learning Disabilities/metabolism , Male , Maze Learning/drug effects , Memory Disorders/chemically induced , Memory Disorders/metabolism , Mice , Mice, Inbred ICR , Phytoestrogens/antagonists & inhibitors , Receptors, Estrogen/agonists , Receptors, Estrogen/antagonists & inhibitors , Receptors, Estrogen/metabolism , Swimming , Tamoxifen/pharmacology
13.
J Pharm Pharmacol ; 62(2): 263-71, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20487207

ABSTRACT

OBJECTIVES: The ameliorating effects of wild ginseng on learning and memory deficits were investigated in rats. METHODS: Rats were treated daily with wild ginseng or cultivated ginseng for 7 days at 30 min before scopolamine injection (2 mg/kg, i.p.). After inducing cognitive impairment by the administration of scopolamine, behavioural assessment using the Morris water maze was performed. Changes in cholinergic system reactivity were also examined by measuring the immunoreactive neurons of choline acetyltransferase and the reactivity of acetylcholinesterase in the hippocampus. KEY FINDINGS: Scopolamine injection induced impaired performance in the water maze test and severe cell losses in hippocampal cholinergic neurons, as indicated by decreased choline acetyltransferase immunoreactivity and increased acetylcholinesterase reactivity. Daily administration of wild ginseng produced a significant improvement in the escape latency for finding the platform in the Morris water maze and reduced the loss of cholinergic immunoreactivity in the hippocampus. The reduced expression of brain-derived neurotrophic factor mRNA due to the scopolamine injection was recovered to normal levels by the administration of wild ginseng. CONCLUSIONS: Wild ginseng demonstrates a significant neuroprotective effect against scopolamine-induced neuronal and cognitive impairment.


Subject(s)
Acetylcholine/antagonists & inhibitors , Cholinergic Antagonists/toxicity , Hippocampus/drug effects , Neuroprotective Agents/pharmacology , Panax/chemistry , Plant Extracts/pharmacology , Scopolamine/toxicity , Acetylcholinesterase/metabolism , Animals , Brain-Derived Neurotrophic Factor/biosynthesis , Cell Count , Choline O-Acetyltransferase/metabolism , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Hippocampus/enzymology , Hippocampus/metabolism , Hippocampus/pathology , Immunohistochemistry , Male , Maze Learning/drug effects , Memory/drug effects , Neurons/drug effects , Neurons/enzymology , Neurons/metabolism , Neurons/pathology , Neuroprotective Agents/isolation & purification , Panax/growth & development , Plant Extracts/isolation & purification , Plant Roots/chemistry , Plant Roots/growth & development , RNA, Messenger/biosynthesis , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction
14.
Pharmacol Res ; 55(5): 450-4, 2007 May.
Article in English | MEDLINE | ID: mdl-17368042

ABSTRACT

PURPOSE: The objective was to validate an in vivo model for evaluation of pharmacological effects on bladder function taking the most predominant anticholinergic side effect (hyposalivation) into account. Therefore, two anticholinergic properties (propiverine hydrochloride and tolterodine-L(+)-tartrate) were used to test the in vivo model. Sacral anterior root stimulation (SARS) was performed to induce reproducible and standardized bladder contractions. To evaluate hyposalivation standardised salivavary flow measurements by stimulating the lingual nerve was performed in addition to SARS. MATERIALS AND METHODS: 10 male mini pigs were anaesthetised. The carotid artery was cannulated for blood pressure measurement and the jugular vein for administration of propiverine 0.4 mg kg(-1) b.w. and tolterodine 0.06 mg kg(-1) b.w. For stimulation-induced salivary flow measurements both lingual nerves were exposed and a cuff electrode was placed around the nerves. The bladder was exposed and a cystostomy catheter was inserted to performed cystometrographic measurements during SARS. RESULTS: In all experiments, for each animal reproducible intravesical pressure values (pves) and salivary flow rates were elicited during electrostimulation before administration of the drug. Bladder pressure: After administration of propiverine, neurostimulation-induced rise in pves had fallen by 60% from the initial value. After administration of tolterodine pves had fallen by about 50%. After additional administration of atropine pves decreased to about 15% of the initial value for both drugs. Salivation: After propiverine salivary flow had fallen by 61%. Inhibition of salivary flow under tolterodine was about 56%. Additional administration of atropine led in both drugs to a nearly complete blockade of salivation. Heart rate (HR) and blood pressure (BP): Directly following intravenous administration of both drugs, a short-term and reversible period of mild but significant fluctuations in HR was observed. There was also a slight but non-significant rise in blood pressure. CONCLUSIONS: This model allows comparative investigations of various drugs with bladder inhibitory properties in terms of acute efficacy and side effects.


Subject(s)
Cholinergic Antagonists/pharmacology , Drug Evaluation, Preclinical/standards , Muscle Contraction/drug effects , Salivary Glands/drug effects , Salivation/drug effects , Swine, Miniature , Urinary Bladder/drug effects , Xerostomia/chemically induced , Animals , Atropine/pharmacology , Benzhydryl Compounds/pharmacology , Benzilates/pharmacology , Blood Pressure/drug effects , Cholinergic Antagonists/toxicity , Cresols/pharmacology , Drug Evaluation, Preclinical/methods , Electric Stimulation , Heart Rate/drug effects , Lingual Nerve , Male , Models, Animal , Phenylpropanolamine/pharmacology , Reproducibility of Results , Salivary Glands/innervation , Salivary Glands/physiopathology , Swine , Tolterodine Tartrate , Urinary Bladder/innervation , Xerostomia/physiopathology
15.
Xenobiotica ; 31(8-9): 633-50, 2001.
Article in English | MEDLINE | ID: mdl-11569530

ABSTRACT

1. Torsades de pointes (TDP) is a potentially fatal ventricular tachycardia associated with increases in QT interval and monophasic action potential duration (MAPD). TDP is a side-effect that has led to withdrawal of several drugs from the market (e.g. terfenadine and terodiline). 2. The potential of compounds to cause TDP was evaluated by monitoring their effects on MAPD in dog. Four compounds known to increase QT interval and cause TDP were investigated: terfenadine, terodiline, cisapride and E4031. On the basis that only free drug in the systemic circulation will elicit a pharmacological response target, free concentrations in plasma were selected to mimic the free drug exposures in man. Infusion regimens were designed that rapidly achieved and maintained target-free concentrations of these drugs in plasma and data on the relationship between free concentration and changes in MAPD were obtained for these compounds. 3. These data indicate that the free ED50 in plasma for terfenadine (1.9 nM), terodiline (76 nM), cisapride (11 nM) and E4031 (1.9 nM) closely correlate with the free concentration in man causing QT effects. For compounds that have shown TDP in the clinic (terfenadine, terodiline, cisapride) there is little differentiation between the dog ED50 and the efficacious free plasma concentrations in man (< 10-fold) reflecting their limited safety margins. These data underline the need to maximize the therapeutic ratio with respect to TDP in potential development candidates and the importance of using free drug concentrations in pharmacokinetic/pharmacodynamic studies.


Subject(s)
Butylamines/toxicity , Cisapride/toxicity , Piperidines/toxicity , Pyridines/toxicity , Terfenadine/toxicity , Torsades de Pointes/chemically induced , Action Potentials/drug effects , Animals , Anti-Arrhythmia Agents/pharmacokinetics , Anti-Arrhythmia Agents/pharmacology , Anti-Arrhythmia Agents/toxicity , Blood Proteins/metabolism , Butylamines/pharmacokinetics , Butylamines/pharmacology , Calcium Channel Blockers/pharmacokinetics , Calcium Channel Blockers/pharmacology , Calcium Channel Blockers/toxicity , Cholinergic Antagonists/pharmacokinetics , Cholinergic Antagonists/pharmacology , Cholinergic Antagonists/toxicity , Cisapride/pharmacokinetics , Cisapride/pharmacology , Dogs , Drug Evaluation, Preclinical , Gastrointestinal Agents/pharmacokinetics , Gastrointestinal Agents/pharmacology , Gastrointestinal Agents/toxicity , Histamine H1 Antagonists/pharmacokinetics , Histamine H1 Antagonists/pharmacology , Histamine H1 Antagonists/toxicity , Humans , Male , Piperidines/pharmacokinetics , Piperidines/pharmacology , Protein Binding , Pyridines/pharmacokinetics , Pyridines/pharmacology , Safety , Terfenadine/pharmacokinetics , Terfenadine/pharmacology , Torsades de Pointes/physiopathology
16.
Rev. argent. anestesiol ; 59(1): 32-9, ene.-feb. 2001. tab, graf
Article in Spanish | LILACS | ID: lil-288446

ABSTRACT

El Síndrome Neuroléptico Maligno es una enfermedad rara pero con alta mortalidad, por lo cual es conveniente tenerla presente ante la aparición de un cuadro de hipertermia inducido por drogas. En ocasiones la presentación clínica suele ser indistinguible de una Hipertermia Maligna, si bien su mecanismo fisiopatológico es completamente diferente. Sus características clínicas comprenden hipertermia, rigidez muscular, elevación de la creatininfosfoquinasa (C.P.K.) además de mioglobinemia y mioglobinuria, como consecuencia de la rabdomiólisis. En esta recopilación mencionaremos su fisiopatología, etiología, criterios clínicos, su relación con Hipertermia maligna y los detalles de su tratamiento.


Subject(s)
Humans , Diagnosis, Differential , Dopamine Antagonists/adverse effects , Hyperthermia, Induced/adverse effects , Hyperthermia, Induced/mortality , Recurrence , Neuroleptic Malignant Syndrome/etiology , Neuroleptic Malignant Syndrome/physiopathology , Neuroleptic Malignant Syndrome/therapy , Antipsychotic Agents , Antipsychotic Agents/adverse effects , Cholinergic Antagonists/toxicity , Catatonia/diagnosis , Catatonia/mortality , Dantrolene/therapeutic use , Encephalitis, Viral/diagnosis , Muscle Rigidity/etiology , Risk Factors , Serotonin Syndrome/congenital
17.
Rev. argent. anestesiol ; 59(1): 32-9, ene.-feb. 2001. tab, graf
Article in Spanish | BINACIS | ID: bin-10179

ABSTRACT

El Síndrome Neuroléptico Maligno es una enfermedad rara pero con alta mortalidad, por lo cual es conveniente tenerla presente ante la aparición de un cuadro de hipertermia inducido por drogas. En ocasiones la presentación clínica suele ser indistinguible de una Hipertermia Maligna, si bien su mecanismo fisiopatológico es completamente diferente. Sus características clínicas comprenden hipertermia, rigidez muscular, elevación de la creatininfosfoquinasa (C.P.K.) además de mioglobinemia y mioglobinuria, como consecuencia de la rabdomiólisis. En esta recopilación mencionaremos su fisiopatología, etiología, criterios clínicos, su relación con Hipertermia maligna y los detalles de su tratamiento. (AU)


Subject(s)
Humans , Neuroleptic Malignant Syndrome/etiology , Neuroleptic Malignant Syndrome/physiopathology , Neuroleptic Malignant Syndrome/therapy , Hyperthermia, Induced/adverse effects , Hyperthermia, Induced/mortality , Dopamine Antagonists/adverse effects , Diagnosis, Differential , Recurrence , Muscle Rigidity/etiology , Dantrolene/therapeutic use , Antipsychotic Agents , Antipsychotic Agents/adverse effects , Risk Factors , Catatonia/diagnosis , Catatonia/mortality , Serotonin Syndrome/congenital , Encephalitis, Viral/diagnosis , Cholinergic Antagonists/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL